| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.
|
Clin Infect Dis
|
2004
|
9.21
|
|
2
|
Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities.
|
Clin Infect Dis
|
2008
|
1.97
|
|
3
|
In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.
|
Antimicrob Agents Chemother
|
2004
|
1.72
|
|
4
|
In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
|
Antimicrob Agents Chemother
|
2010
|
1.40
|
|
5
|
Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities.
|
Diagn Microbiol Infect Dis
|
2010
|
1.35
|
|
6
|
Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology.
|
Clin Infect Dis
|
2004
|
1.30
|
|
7
|
Identification of carbapenem-resistant klebsiella pneumoniae harboring KPC enzymes in New Jersey.
|
Microb Drug Resist
|
2007
|
1.27
|
|
8
|
Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV.
|
Antimicrob Agents Chemother
|
2004
|
1.20
|
|
9
|
Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance.
|
Antimicrob Agents Chemother
|
2005
|
1.09
|
|
10
|
Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin.
|
Antimicrob Agents Chemother
|
2004
|
1.04
|
|
11
|
Identification of CTX-M β-lactamases among Escherichia coli from the community in New York City.
|
Diagn Microbiol Infect Dis
|
2012
|
1.01
|
|
12
|
Polymyxin-resistant clinical isolates of Escherichia coli.
|
Antimicrob Agents Chemother
|
2010
|
0.94
|
|
13
|
Increased mortality associated with a clonal outbreak of ceftazidime-resistant Klebsiella pneumoniae: a case-control study.
|
Infect Control Hosp Epidemiol
|
2005
|
0.90
|
|
14
|
Polymyxin Combination Therapy and the Use of Serum Bactericidal Titers in the Management of KPC-Producing Klebsiella pneumoniae Infections: A Report of 3 Cases.
|
Case Rep Med
|
2011
|
0.88
|
|
15
|
Community-associated Escherichia coli harboring CTX-M β-lactamases from urine cultures from pediatric patients.
|
Antimicrob Agents Chemother
|
2012
|
0.86
|
|
16
|
Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection.
|
Infect Control Hosp Epidemiol
|
2007
|
0.85
|
|
17
|
Unrelated strain methicillin-resistant Staphylococcus aureus colonization of health care workers in a neonatal intensive care unit: findings of an outbreak investigation.
|
Am J Infect Control
|
2013
|
0.81
|
|
18
|
Identification of extended-spectrum-β-lactamase-positive Klebsiella pneumoniae urinary tract isolates harboring KPC and CTX-M β-lactamases in nonhospitalized patients.
|
Antimicrob Agents Chemother
|
2013
|
0.77
|
|
19
|
Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
|
Microb Drug Resist
|
2011
|
0.77
|
|
20
|
Use of daptomycin for the treatment of methicillin-resistant coagulase-negative staphylococcal ventriculitis.
|
Case Rep Med
|
2012
|
0.75
|